Sign in
Episode 14: Plasma VEGF Levels After Anti-VEGF Injections (DRCR protocol T) with Dr. Charles Wykoff
Keyvan Koushan, MD, FRCSC
Member Podcasts
2018
First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Previous Intravitreal Therapy is Associated With Increased Risk of Posterior Capsule Rupture During Cataract Surgery
Aaron Y Lee, MD, MSCI
Updates from the Field
2016
Category: Pharmacology-AntiVEGF